Literature DB >> 1325642

Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells.

L Karran1, Y Gao, P R Smith, B E Griffin.   

Abstract

A major family of polyadenylylated cytoplasmic transcripts are expressed from the BamHI A-I region of the Epstein-Barr virus genome, off the strand complementary to that encoding several functions associated with viral replication and the lytic cycle, including the DNA polymerase (BALF-5). These complementary-strand transcripts (the main one is about 4.8 kilobases long), expressed in all cell types associated with Epstein-Barr virus, are present at high levels in nasopharyngeal carcinoma tumors. Sequence analysis of clones that correspond to spliced transcripts in a cDNA library from such a tumor, C15, generates a profile of the main complementary mRNA. It contains at least three AUG-initiated open reading frames, the largest of which could be translated to give a polypeptide of about 20 kDa. Evidence from several types of experiments suggests that conditions which support the up (or down) regulation of transcriptional expression from one viral DNA strand within the relevant region of the genome produce the opposite effect on transcripts from the other strand. The capacity for interference between complementary Epstein-Barr viral transcripts offers a mechanism for control of gene expression that may be related to maintenance of viral latency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325642      PMCID: PMC49855          DOI: 10.1073/pnas.89.17.8058

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

3.  Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.

Authors:  B D Parker; A Bankier; S Satchwell; B Barrell; P J Farrell
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.

Authors:  C Desgranges; G Lenoir; G de-Thé; J M Seigneurin; J Hilgers; P Dubouch
Journal:  Biomedicine       Date:  1976-12-05

6.  Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.

Authors:  G Bauer
Journal:  J Gen Virol       Date:  1983-06       Impact factor: 3.891

7.  Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas.

Authors:  P Busson; G Ganem; P Flores; F Mugneret; B Clausse; B Caillou; K Braham; H Wakasugi; M Lipinski; T Tursz
Journal:  Int J Cancer       Date:  1988-10-15       Impact factor: 7.396

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy.

Authors:  J S Sham; W I Wei; Y S Zong; D Choy; Y Q Guo; Y Luo; Z X Lin; M H Ng
Journal:  Lancet       Date:  1990-02-17       Impact factor: 79.321

10.  EBV gene expression in an NPC-related tumour.

Authors:  M M Hitt; M J Allday; T Hara; L Karran; M D Jones; P Busson; T Tursz; I Ernberg; B E Griffin
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  30 in total

1.  Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors:  Y Gao; S a Xue; B E Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus.

Authors:  P R Smith; O de Jesus; D Turner; M Hollyoake; C E Karstegl; B E Griffin; L Karran; Y Wang; S D Hayward; P J Farrell
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Expression of two related viral early genes in Epstein-Barr virus-associated tumors.

Authors:  S A Xue; Q L Lu; R Poulsom; L Karran; M D Jones; B E Griffin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.

Authors:  I K Ruf; P W Rhyne; C Yang; J L Cleveland; J T Sample
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Authors:  Aron R Marquitz; Anuja Mathur; Kathy H Y Shair; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

Review 6.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

7.  Modulation of LMP1 protein expression by EBV-encoded microRNAs.

Authors:  Angela Kwok Fung Lo; Ka Fai To; Kwok Wai Lo; Raymond Wai Ming Lung; Jan Wai Ying Hui; Gangling Liao; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

8.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

Authors:  N Kienzle; T B Sculley; L Poulsen; M Buck; S Cross; N Raab-Traub; R Khanna
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi.

Authors:  Y Gao; P R Smith; L Karran; Q L Lu; B E Griffin
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.